Mitapivat sulfate

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameMitapivat sulfate
Drug Alias NameMitapivat-sulfateMitapivat - Agios PharmaceuticalsAG-348-sulfate-hydrateMitapivatPyrukynd +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate kinase activators
TargetsPyruvate kinase
Therapy Area/IndicationsPyruvate kinase deficiencybeta-Thalassemiaalpha-Thalassemia +[9] 
Global Approved IndicationsPyruvate kinase deficiencyAnemia, Hemolytic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/02/17
Country/TerritoryCzechiaBelgiumBulgaria +[30] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAgios Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Health Clinical Center (Cc)Agios Netherlands BvNational Heart, Lung, And Blood Institute (Nhlbi) +[5] 
Inactive CompaniesN/A
Active IndicationsPyruvate kinase deficiencybeta-Thalassemiaalpha-Thalassemia +[8] 
Inactive IndicationsKidney Diseases

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG